Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Orders over $200 ship free anywhere in the country, and ordering five or more vials triggers an automatic 15% bulk discount, bringing the per-vial cost down to 23,460
This randomised, double-blind, placebo-controlled trial enrolled 706 adults with overweight or obesity (BMI 27 or above) across multiple dose groups, running over 26 weeks
Reconstituted solution is more vulnerable because hydrolysis, contamination risk, temperature swings, and repeated vial access all become more important
Combined Phase 1 and 2: 90 units used, 3 mg consumed, 7 mg remaining
Ufnalska I, Drew SC, Zhukov I, Szutkowski K, Wawrzyniak UE, Wroblewski W, et al
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
